v3.25.2
UNAUDITED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' (DEFICIT) / EQUITY - USD ($)
$ in Thousands
Ordinary shares
Additional paid-in capital
Accumulated other comprehensive loss
Accumulated deficit
Total
Beginning balance at Dec. 31, 2023 $ 2,883 $ 1,148,749 $ (53,553) $ (890,409) $ 207,670
Beginning balance (in shares) at Dec. 31, 2023 47,833,830        
Increase (decrease) in shareholders' (deficit) / equity          
Loss for the period       (121,917) (121,917)
Other comprehensive loss, net     (2,767)   (2,767)
Restricted and performance share units distributed during the period $ 46 (46)      
Restricted and performance share units distributed during the period (in shares) 850,589        
Share-based compensation expense   14,071     14,071
Issuance of ordinary shares relating to employee stock purchase plan $ 1 49     50
Issuance of ordinary shares relating to employee stock purchase plan (in shares) 10,150        
Ending balance at Jun. 30, 2024 $ 2,930 1,162,823 (56,320) (1,012,326) 97,107
Ending balance (in shares) at Jun. 30, 2024 48,694,569        
Beginning balance at Mar. 31, 2024 $ 2,919 1,155,904 (56,042) (956,027) 146,754
Beginning balance (in shares) at Mar. 31, 2024 48,492,357        
Increase (decrease) in shareholders' (deficit) / equity          
Loss for the period       (56,299) (56,299)
Other comprehensive loss, net     (278)   (278)
Restricted and performance share units distributed during the period $ 10 (10)      
Restricted and performance share units distributed during the period (in shares) 192,062        
Share-based compensation expense   6,880     6,880
Issuance of ordinary shares relating to employee stock purchase plan $ 1 49     50
Issuance of ordinary shares relating to employee stock purchase plan (in shares) 10,150        
Ending balance at Jun. 30, 2024 $ 2,930 1,162,823 (56,320) (1,012,326) 97,107
Ending balance (in shares) at Jun. 30, 2024 48,694,569        
Beginning balance at Dec. 31, 2024 $ 2,945 1,173,068 (52,800) (1,129,965) $ (6,752)
Beginning balance (in shares) at Dec. 31, 2024 48,988,087       48,988,087
Increase (decrease) in shareholders' (deficit) / equity          
Loss for the period       (81,356) $ (81,356)
Other comprehensive loss, net     (6,103)   (6,103)
Follow-on public offering $ 261 80,250     80,511
Follow-on public offering (in shares) 5,073,529        
Exercises of share options $ 1 202     203
Exercises of share options (in shares) 21,240        
Restricted and performance share units distributed during the period $ 43 (43)      
Restricted and performance share units distributed during the period (in shares) 782,817        
Share-based compensation expense   9,494     9,494
Ending balance at Jun. 30, 2025 $ 3,250 1,262,971 (58,903) (1,211,321) $ (4,003)
Ending balance (in shares) at Jun. 30, 2025 54,865,673       54,865,673
Beginning balance at Mar. 31, 2025 $ 3,240 1,257,853 (53,805) (1,173,602) $ 33,686
Beginning balance (in shares) at Mar. 31, 2025 54,698,479        
Increase (decrease) in shareholders' (deficit) / equity          
Loss for the period       (37,719) (37,719)
Other comprehensive loss, net     (5,098)   (5,098)
Exercises of share options   44     44
Exercises of share options (in shares) 5,312        
Restricted and performance share units distributed during the period $ 10 (10)      
Restricted and performance share units distributed during the period (in shares) 161,882        
Share-based compensation expense   5,084     5,084
Ending balance at Jun. 30, 2025 $ 3,250 $ 1,262,971 $ (58,903) $ (1,211,321) $ (4,003)
Ending balance (in shares) at Jun. 30, 2025 54,865,673       54,865,673